Assessment of 6-thioguanine nucleotide metabolite level in inflammatory bowel disease patients treated with azathioprine

被引：0
|
作者：
Pavlovska, K. [1 ]
Miceska, M. Slaninka [1 ]
Mishevska, P. [2 ]
Ribarska, J. Tonic [3 ]
Atanasovska, E. [1 ]
Kikerkov, I. [1 ]
Efremovska, L. [4 ]
Petrushevska, M. [1 ]
机构：
[1] Fac Med, Dept Preclin & Clin Pharmacol & Toxicol, Skopje, Macedonia
[2] Fac Med, Gastroenterohepatol Clin, Skopje, Macedonia
[3] Fac Pharm, Skopje, Macedonia
[4] Fac Med, Inst Physiol, Skopje, Macedonia
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P533
引用
收藏
页码：S371 / S371
页数：1
相关论文
共 50 条
  • [1] Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease
    Cuffari, C
    Hunt, S
    Bayless, T
    GUT, 2001, 48 (05) : 642 - 646
  • [2] High Thiopurine Methyltransferase Activity Does Not Affect Concentration of Azathioprine Metabolite 6-Thioguanine Nucleotide in Inflammatory Bowel Disease
    Jonason, David
    Sievers, Tyson
    Abraham, James M.
    Vaughn, Byron
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S461 - S462
  • [3] 6-Thioguanine in azathioprine and 6-mercaptopurine intolerant patients with inflammatory bowel disease
    Derijks, LJJ
    De Jong, DJ
    Gilissen, LPL
    Engels, LGJB
    Mulder, CJJ
    Bos, LP
    Lohman, JJHM
    Hooymans, PM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (05) : 546P - 547P
  • [4] The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease
    Goldenberg, BA
    Rawsthorne, P
    Bernstein, CN
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1744 - 1748
  • [5] Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease
    Andoh, Akira
    Tsujikawa, Tomoyuki
    Ban, Hiromitsu
    Hashimoto, Takayoshi
    Bamba, Shigeki
    Ogawa, Atsuhiro
    Sasaki, Masaya
    Saito, Yasuharu
    Fujiyama, Yoshihide
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (09) : 1373 - 1377
  • [6] Thiopurine Metabolite, 6-Thioguanine Nucleotide, Correlates with Detection of Antibodies Against Infliximab in Patients with Inflammatory Bowel Disease
    Mogensen, Ditte
    Brynskov, Jorn
    Ainsworth, Mark
    Nersting, Jacob
    Schmiegelow, Kjeld
    Steenholdt, Casper
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S41 - S42
  • [7] Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease
    Derijks, LJJ
    Gilissen, LPL
    Engels, LGJB
    Bos, LP
    Bus, PJ
    Lohman, JJHM
    van Deventer, SJH
    Hommes, DW
    Hooymans, PM
    THERAPEUTIC DRUG MONITORING, 2006, 28 (01) : 45 - 50
  • [8] Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
    Heerasing, N. M.
    Ng, J. F.
    Dowling, D.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (04) : 465 - 469
  • [9] Allopurinol/azathioprine interactionIncreased level of 6-thioguanine (a metabolite of azathioprine): case report
    Reactions Weekly, 2019, 1745 (1) : 22 - 22
  • [10] Does macrocytosis reflect therapeutic 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
    Beswick, Lauren
    Ting, Alvin Y.
    Hair, Christopher
    Dowling, Damian
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 98 - 98
12345